Background: Retinopathy of prematurity is a vascular retinal disease that can cause blindness in premature new born babies. Several risk factors are associated with the incidence of ROP. Information and data on risk factors associated with ROP in context to Nepalese population is scarcely documented in literature. Objectives: The purpose of this study was to evaluate the risk factors of retinop...

Guidelines on managing infants after initial anti-vascular endothelial growth factor (VEGF) treatment (eg, bevacizumab) for retinopathy of prematurity (ROP) are limited. We found that following bevacizumab ROP, prophylactically lasering infant eyes before hospital discharge reduced the number and duration outpatient ROP screening examinations compared with infants, per current United States (US...

Until recently, the treatment of potentially blinding retinopathy of prematurity (ROP) has been relatively straightforward. The 2003 publication1 of the multicenter ETROP (Early Treatment for Retinopathy of Prematurity) randomized trial indicated improved outcomes with the use of peripheral retinal ablation for eyes with type 1 ROP, defined as zone I ROP with plus disease (ie, abnormal dilation...

The etiology of retinopathy of prematurity (ROP) is multifactorial while ROP is also frequently associated with other co-morbidity characteristics in former preterm infants. We describe the current risk factors associated with the development of pre-threshold ROP in a cohort of 267 ELBW (extreme low birth weight, i.e. < 1 000 g) infants. We hereby confirm the combined risk associated with immat...

OBJECTIVE To describe recognition (letter) acuity at age 10 years in eyes with and without retinal residua of retinopathy of prematurity (ROP). DESIGN Presence and severity of ROP residua were documented by a study ophthalmologist. Masked testers measured monocular recognition visual acuity (Early Treatment of Diabetic Retinopathy Study) when the children were 10 years old. Two hundred forty-...

BACKGROUND Increased survival of extremely low birth infants due to advances in antenatal and neonatal care has resulted in a population of infants at high risk of developing retinopathy of prematurity (ROP). Therapeutic interventions include the use of antenatal and postnatal steroids however, their effects on the severity of ROP is in dispute. In addition, it has not been investigated whether...

PURPOSE To present the final results of the Early Treatment for Retinopathy of Prematurity Study. METHODS Infants with bilateral high-risk prethreshold retinopathy of prematurity (ROP) (n = 317) had one eye randomized to early retinal ablative treatment and the fellow eye managed conventionally (control eye). In asymmetric cases (n = 84), the eye with high-risk prethreshold ROP was randomized...

Background: Retinopathy of prematurity (ROP) is a vasoproliferative retinal disorder that affects extremely premature infants and the leading cause irreversible blindness in childhood. Objective: This study presents review Cochrane systematic reviews about ROP. Methods: We analyzed summarized results all intervention, prevention treatment, from Systematic Reviews (SR) for ROP designed to highes...